CRISPR Therapeutics AG (CRSP)
NASDAQ: CRSP · IEX Real-Time Price · USD
53.37
-2.28 (-4.10%)
Apr 25, 2024, 1:21 PM EDT - Market open
CRISPR Therapeutics AG Market Cap
CRISPR Therapeutics AG has a market cap or net worth of $4.52 billion as of April 25, 2024. Its market cap has increased by 5.80% in one year.
Market Cap
4.52B
Enterprise Value
3.06B
1-Year Change
5.80%
Ranking
Category
Stock Price
$53.26
Market Cap Chart
Since October 19, 2016, CRISPR Therapeutics AG's market cap has increased from $560.10M to $4.52B, an increase of 706.55%. That is a compound annual growth rate of 32.02%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 23, 2024 | 4.53B | 1.35% |
Apr 22, 2024 | 4.47B | 1.11% |
Apr 19, 2024 | 4.42B | -1.98% |
Apr 18, 2024 | 4.51B | 1.08% |
Apr 17, 2024 | 4.46B | -4.14% |
Apr 16, 2024 | 4.65B | -1.29% |
Apr 15, 2024 | 4.71B | -3.21% |
Apr 12, 2024 | 4.87B | -3.56% |
Apr 11, 2024 | 5.05B | 1.90% |
Apr 10, 2024 | 4.96B | -5.29% |
Apr 9, 2024 | 5.23B | 1.72% |
Apr 8, 2024 | 5.14B | 1.89% |
Apr 5, 2024 | 5.05B | -3.32% |
Apr 4, 2024 | 5.22B | 0.71% |
Apr 3, 2024 | 5.19B | -0.66% |
Apr 2, 2024 | 5.22B | -4.62% |
Apr 1, 2024 | 5.47B | 0.03% |
Mar 28, 2024 | 5.47B | -2.85% |
Mar 27, 2024 | 5.63B | -1.14% |
Mar 26, 2024 | 5.70B | -0.15% |
Mar 25, 2024 | 5.71B | -0.74% |
Mar 22, 2024 | 5.75B | -3.88% |
Mar 21, 2024 | 5.98B | 2.14% |
Mar 20, 2024 | 5.86B | 1.36% |
Mar 19, 2024 | 5.78B | 0.69% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Grifols | 5.30B |
Bausch + Lomb | 5.21B |
Glaukos | 5.07B |
Halozyme Therapeutics | 4.95B |
R1 RCM | 4.94B |
Organon & Co. | 4.73B |
BridgeBio Pharma | 4.70B |
Doximity | 4.59B |